NLS Pharmaceutics Ltd. (NASDAQ:NLSPW) Short Interest Update

NLS Pharmaceutics Ltd. (NASDAQ:NLSPW) was the target of a significant drop in short interest in October. As of October 15th, there was short interest totalling 900 shares, a drop of 91.3% from the September 30th total of 10,300 shares. Based on an average daily volume of 13,700 shares, the short-interest ratio is presently 0.1 days.

NLS Pharmaceutics Price Performance

Shares of NLS Pharmaceutics stock remained flat at $0.01 during midday trading on Friday. 4,000 shares of the company were exchanged, compared to its average volume of 16,975. The company’s fifty day moving average is $0.02 and its two-hundred day moving average is $0.03. NLS Pharmaceutics has a fifty-two week low of $0.01 and a fifty-two week high of $0.17.

NLS Pharmaceutics Company Profile

NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD).